Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Baxter To Sell CVG's Products In Fringe International Markets After Spin-off

This article was originally published in The Gray Sheet

Executive Summary

Baxter Healthcare will continue to distribute products produced by its Cardiovascular Group spin-off in several countries outside of the U.S., including Argentina, Australia, Greece, Ireland, New Zealand and certain Scandinavian countries, after CVG Controlled, Inc. becomes a separate entity in the first half of 2000.

You may also be interested in...



Edwards Studies Gene Therapy Compound As Vessel For Peripheral Growth

Edwards Lifesciences' legacy as a Baxter spin-off is allowing the cardiovascular firm to pursue clinical applications of a peripheral artery disease (PAD) gene therapy compound without integrating it with a device

Edwards Studies Gene Therapy Compound As Vessel For Peripheral Growth

Edwards Lifesciences' legacy as a Baxter spin-off is allowing the cardiovascular firm to pursue clinical applications of a peripheral artery disease (PAD) gene therapy compound without integrating it with a device

Edwards Lifesciences Lifepath AAA Graft Fracture Investigation Ongoing

Edwards Lifesciences is continuing to investigate the cause of fractures detected in the wireform scaffolding of its Lifepath endovascular graft system for treatment of abdominal aortic aneurysms, following discovery of the fractures in two patients treated with the device.

Related Content

UsernamePublicRestriction

Register

SC143367

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel